Global Medical REIT Inc (GMRE) concluded trading on Thursday at a closing price of $7.48, with 0.44 million shares of worth about $3.25 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.93% during that period and on April 17, 2025 the price saw a gain of about 1.77%. Currently the company’s common shares owned by public are about 66.87M shares, out of which, 63.10M shares are available for trading.
Stock saw a price change of 6.55% in past 5 days and over the past one month there was a price change of -14.02%. Year-to-date (YTD), GMRE shares are showing a performance of -3.11% which decreased to -4.10% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.75 but also hit the highest price of $10.35 during that period. The average intraday trading volume for Global Medical REIT Inc shares is 519.05K. The stock is currently trading -5.58% below its 20-day simple moving average (SMA20), while that difference is down -9.66% for SMA50 and it goes to -14.48% lower than SMA200.
Global Medical REIT Inc (NYSE: GMRE) currently have 66.87M outstanding shares and institutions hold larger chunk of about 63.28% of that.
The stock has a current market capitalization of $540.20M and its 3Y-monthly beta is at 1.30. PE ratio of stock for trailing 12 months is 628.57, while it has posted earnings per share of $0.01 in the same period. Its PEG reads 6.57 while making debt-to-equity ratio of 1.23. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GMRE, volatility over the week remained 3.04% while standing at 4.08% over the month.
Stock’s fiscal year EPS is expected to rise by 600.00% while it is estimated to decrease by -45.71% in next year. EPS is likely to grow at an annualized rate of 95.74% for next 5-years, compared to annual growth of -34.34% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by B. Riley Securities on April 03, 2025 offering a Neutral rating for the stock and assigned a target price of $9 to it. Coverage by Berenberg stated Global Medical REIT Inc (GMRE) stock as a Buy in their note to investors on October 18, 2024, suggesting a price target of $11.75 for the stock. On September 19, 2024, Alliance Global Partners Initiated their recommendations, while on October 10, 2022, Robert W. Baird Downgrade their ratings for the stock with a price target of $9. Stock get a Market perform rating from BMO Capital Markets on October 06, 2022.
